Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Key Points

• Wells Fargo & Company has raised its target price for Sabra Healthcare REIT from $20.00 to $21.00, indicating a potential upside of 9.09% from the previous close.
• Several analysts have recently upgraded their ratings on SBRA, with JMP Securities setting a price target of $22.00, suggesting strong investment interest.
• Sabra Healthcare REIT reported $0.38 earnings per share for the last quarter, exceeding expectations and showing a year-over-year revenue increase of 7.4%.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) had its target price increased by equities researchers at Wells Fargo & Company from $20.00 to $21.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an "overweight" rating on the real estate investment trust's stock. Wells Fargo & Company's target price would suggest a potential upside of 9.09% from the company's previous close.

SBRA has been the subject of a number of other reports. JMP Securities increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. BMO Capital Markets raised their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday. Finally, Scotiabank raised their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $20.43.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock traded up $0.06 during midday trading on Wednesday, reaching $19.25. 110,553 shares of the company traded hands, compared to its average volume of 2,447,786. The firm has a market capitalization of $4.62 billion, a price-to-earnings ratio of 25.34, a price-to-earnings-growth ratio of 1.53 and a beta of 0.86. The business has a 50 day moving average of $18.49 and a two-hundred day moving average of $17.73. Sabra Healthcare REIT has a 12 month low of $15.60 and a 12 month high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the firm earned $0.36 earnings per share. The company's quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, research analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several institutional investors have recently made changes to their positions in SBRA. Geode Capital Management LLC lifted its holdings in Sabra Healthcare REIT by 0.8% during the 2nd quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust's stock valued at $121,960,000 after buying an additional 55,200 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Sabra Healthcare REIT by 1.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 4,175,058 shares of the real estate investment trust's stock valued at $76,988,000 after buying an additional 60,843 shares in the last quarter. Northern Trust Corp lifted its holdings in Sabra Healthcare REIT by 27.7% during the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock valued at $72,214,000 after buying an additional 905,466 shares in the last quarter. Nuveen LLC bought a new stake in Sabra Healthcare REIT during the 1st quarter valued at about $61,791,000. Finally, Janus Henderson Group PLC lifted its holdings in Sabra Healthcare REIT by 23.1% during the 4th quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock valued at $60,720,000 after buying an additional 657,950 shares in the last quarter. Institutional investors own 99.40% of the company's stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.